Aga Nanotech
AGA Nanotech is dedicated to combating antimicrobial resistance (AMR) through innovative solutions, primarily focusing on their proprietary antimicrobial delivery system, Battlestar. Their mission is to develop and commercialize non-antibiotic antimicrobial technologies that address critical clinical needs, reduce resistance, and support tissue repair. They collaborate with global research institutions, healthcare providers, and industry partners to advance their technology and improve patient outcomes.
Industries
Products
PLGA microparticle-based antimicrobial delivery system
A biodegradable microparticle platform that releases precursor chemicals which generate peracetic acid and hydrogen peroxide in situ to provide sustained broad‑spectrum antimicrobial activity with reduced cytotoxicity.
PLGA microparticle-based antimicrobial delivery system
A biodegradable microparticle platform that releases precursor chemicals which generate peracetic acid and hydrogen peroxide in situ to provide sustained broad‑spectrum antimicrobial activity with reduced cytotoxicity.
Services
R&D collaborations and translational development
Collaborative development of antimicrobial delivery systems, including formulation, particle manufacture, preclinical testing, and clinical application planning.
Licensing and technology transfer
Out‑licensing and commercial partnerships for microparticle manufacturing technology and associated formulations.
Preclinical efficacy and analytical assessment
Microbiological testing, in vitro/in vivo efficacy assessment, cytotoxicity profiling, and microbiome/AMR gene analysis to support product development.
R&D collaborations and translational development
Collaborative development of antimicrobial delivery systems, including formulation, particle manufacture, preclinical testing, and clinical application planning.
Licensing and technology transfer
Out‑licensing and commercial partnerships for microparticle manufacturing technology and associated formulations.
Preclinical efficacy and analytical assessment
Microbiological testing, in vitro/in vivo efficacy assessment, cytotoxicity profiling, and microbiome/AMR gene analysis to support product development.
Expertise Areas
- Antimicrobial delivery systems
- Controlled-release biodegradable microparticles
- Antibiofilm strategies
- Wound care therapeutics
Key Technologies
- PLGA-based biodegradable microparticles
- Thermally Induced Phase Separation (TIPS)
- In-situ generation of peracetic acid and hydrogen peroxide
- Precursor chemistry (sodium percarbonate, acetyl donors)